Ara Koh, Filipe De Vadder, Petia Kovatcheva-Datchary, Fredrik Bäckhed 

Slides:



Advertisements
Similar presentations
Immunity in the Gut Andrew M. Platt, University of Glasgow, UK
Advertisements

Laurence Macia, PhD 5th European Immunology & Innate Immunity
Volatile fatty acids.
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Obesity and the Microbiota
Volatile fatty acids.
Obesity and Cancer: The Oil that Feeds the Flame
Aspirin use and endometrial cancer risk and survival
Gut matters: Microbe-host interactions in allergic diseases
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Volume 18, Issue 4, Pages (October 2015)
Specialized Metabolites from the Microbiome in Health and Disease
Gut Microbiota: The Link to Your Second Brain
Microbial Influences in Inflammatory Bowel Diseases
Interleukin-18: The Bouncer at the Mucosal Bar
From Hype to Hope: The Gut Microbiota in Enteric Infectious Disease
Gut Microbes Make for Fattier Fish
Checks and Balances: IL-23 in the Intestine
Bryan B. Yoo, Sarkis K. Mazmanian  Immunity 
Metabolic control of regulatory T cell development and function
Specialized Metabolites from the Microbiome in Health and Disease
The Intestinal Immune System in Obesity and Insulin Resistance
Central Nervous System Mechanisms Linking the Consumption of Palatable High-Fat Diets to the Defense of Greater Adiposity  Karen K. Ryan, Stephen C. Woods,
Volatile fatty acids.
Salmonella Typhimurium Diarrhea Reveals Basic Principles of Enteropathogen Infection and Disease-Promoted DNA Exchange  Sandra Y. Wotzka, Bidong D. Nguyen,
Diet, Metabolites, and “Western-Lifestyle” Inflammatory Diseases
Commensal Fungi in Health and Disease
Control of Brain Development, Function, and Behavior by the Microbiome
From Hype to Hope: The Gut Microbiota in Enteric Infectious Disease
Arming Treg Cells at the Inflammatory Site
Lung Homeostasis: Influence of Age, Microbes, and the Immune System
Figure 1 Influence of diet on gut microbiota and blood pressure
Signaling in Host-Associated Microbial Communities
[Br]eaking FAt Cell Volume 159, Issue 2, Pages (October 2014)
Pathways in Microbe-Induced Obesity
The Origins and Drivers of Insulin Resistance
Gut-Pancreatic Axis AMPlified in Islets of Langerhans
GPCR-Mediated Signaling of Metabolites
Bridging immunity and lipid metabolism by gut microbiota
Figure 2 Microbiota-related pathways in atherosclerosis
The Role of Retinoic Acid in Tolerance and Immunity
Metabolic Instruction of Immunity
Chengcheng Jin, Jorge Henao-Mejia, Richard A. Flavell  Cell Metabolism 
Microbes, Microbiota, and Colon Cancer
Targeting Bacterial Central Metabolism for Drug Development
Obesity and the Microbiota
Interleukin-18: The Bouncer at the Mucosal Bar
Role of the Microbiota in Immunity and Inflammation
Gut Microbes Make for Fattier Fish
Salmonella Typhimurium Diarrhea Reveals Basic Principles of Enteropathogen Infection and Disease-Promoted DNA Exchange  Sandra Y. Wotzka, Bidong D. Nguyen,
The Fire Within: Microbes Inflame Tumors
Varman T. Samuel, Gerald I. Shulman  Cell Metabolism 
Elizabeth A. Cameron, Vanessa Sperandio  Cell Host & Microbe 
Homeostasis and Inflammation in the Intestine
Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System  Thomas Siegmund Postler, Sankar Ghosh  Cell Metabolism 
Dan R. Littman, Eric G. Pamer  Cell Host & Microbe 
Interleukin-18 in Intestinal Inflammation: Friend and Foe?
A New “Immunological” Role for Adipocytes in Obesity
Asthma Prevention: Right Bugs, Right Time?
The Immune System as a Sensor of the Metabolic State
Inflammatory pathways in alcoholic steatohepatitis
Kian Fan Chung, MD, DSc, FRCP 
Learning Tolerance while Fighting Ignorance
Sander Lefere, Frank Tacke  JHEP Reports 
Gut-Brain Glucose Signaling in Energy Homeostasis
Muriel Derrien, Johan E.T. van Hylckama Vlieg  Trends in Microbiology 
Matthew D. Weitzman, Jonathan B. Weitzman  Cell Host & Microbe 
Cooperative Microbial Tolerance Behaviors in Host-Microbiota Mutualism
Clara Abraham, Ruslan Medzhitov  Gastroenterology 
Host and Microbes Date Exclusively
Presentation transcript:

From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites  Ara Koh, Filipe De Vadder, Petia Kovatcheva-Datchary, Fredrik Bäckhed  Cell  Volume 165, Issue 6, Pages 1332-1345 (June 2016) DOI: 10.1016/j.cell.2016.05.041 Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 1 Known Pathways for Biosynthesis of SCFAs from Carbohydrate Fermentation and Bacterial Cross-Feeding The microbial conversion of dietary fiber in the gut results in synthesis of the three major SCFAs, acetate, propionate, and butyrate. Acetate is produced from pyruvate via acetyl-CoA and also via the Wood-Ljungdahl pathway. Butyrate is synthesized from two molecules of acetyl-CoA, yielding acetoacetyl-CoA, which is further converted to butyryl-CoA via β-hydroxybutyryl-CoA and crotonyl-CoA. Propionate can be formed from PEP through the succinate pathway or the acrylate pathway, in which lactate is reduced to propionate. Microbes can also produce propionate through the propanediol pathway from deoxyhexose sugars, such as fucose and rhamnose. PEP, phosphoenolpyruvate; DHAP, dihydroxyacetonephosphate. Cell 2016 165, 1332-1345DOI: (10.1016/j.cell.2016.05.041) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 2 Mechanism of Action of Microbially Produced SCFAs Fermentation of dietary fiber leads to the production of SCFAs via various biochemical pathways. The size of the letters symbolizes the ratio of SCFAs present. In the distal gut, SCFAs can enter the cells through diffusion or SLC5A8-mediated transport and act as an energy source or an HDAC inhibitor. Luminal acetate or propionate sensed by GPR41 and GPR43 releases PYY and GLP-1, affecting satiety and intestinal transit. Luminal butyrate exerts anti-inflammatory effects via GPR109A and HDAC inhibition. Furthermore, propionate can be converted into glucose by IGN, leading to satiety and decreased hepatic glucose production. SCFAs can also act on other sites in the gut, like the ENS, where they stimulate motility and secretory activity, or the immune cells in the lamina propria, where they reduce inflammation and tumorigenesis. Small amounts of SCFAs (mostly acetate and possibly propionate) reach the circulation and can also directly affect the adipose tissue, brain, and liver, inducing overall beneficial metabolic effects. Solid arrows indicate the direct action of each SCFA, and dashed arrows from the gut are indirect effects. Cell 2016 165, 1332-1345DOI: (10.1016/j.cell.2016.05.041) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 3 Impact of SCFA-Mediated Tolerance and Immunity in Intestinal and Allergic Airway Inflammation To maintain homeostasis, our immune system should remain suppressive. Tolerance to commensals (tolerating self-molecules) is primarily achieved by IL-18 increase in intestinal epithelium and immune-suppressive Treg expansion/differentiation through Treg itself or DC. These effects are mediated by the interaction between SCFAs and their targets in the host (GPCR and/or HDAC), which is also important in the suppression of inflammation outside of the gut—dysregulation of immune tolerance can lead to allergic airway inflammation (asthma). However, host immune system should recognize and eliminate pathogens (non-self) by activating effector T cell functions, which are also known to be regulated by SCFA-mediated HDAC inhibition and mTORC1 activation, depending on immunological milieu. Cell 2016 165, 1332-1345DOI: (10.1016/j.cell.2016.05.041) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 4 Context-Dependent Effects of Microbiota on CRC Depending on the cellular context of the host (i.e., inflammation-driven or acquisition of stem-cell-like character), antibiotics and/or SCFAs can function as anti-inflammatory or pro-inflammatory. In normal conditions in which commensal-host interaction is nicely balanced, removal of commensals by antibiotics will erase the beneficial effect of SCFAs, contributing to CRC development. Cell 2016 165, 1332-1345DOI: (10.1016/j.cell.2016.05.041) Copyright © 2016 Elsevier Inc. Terms and Conditions